May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Invetigation of Cornea-Derived Transcript 6 (CDT6) as a Potential Glaucoma Protein
J. Kuchtey; M. Curtis; K. Gelatt; M. Kallberg; T. Rinkoski; A. Komaromy; R. Kuchtey
Author Affiliations & Notes
  • J. Kuchtey
    Vanderbilt University, Nashville, Tennessee
    Dept of Ophthalmology and Visual Sciences,
  • M. Curtis
    Vanderbilt University, Nashville, Tennessee
    Vanderbilt Vision Research Center,
  • K. Gelatt
    Small Animal Clinical Sciences, University of Florida, College of Veterinary Medicine, Gainesville, Florida
  • M. Kallberg
    Small Animal Clinical Sciences, University of Florida, College of Veterinary Medicine, Gainesville, Florida
  • T. Rinkoski
    Small Animal Clinical Sciences, University of Florida, College of Veterinary Medicine, Gainesville, Florida
  • A. Komaromy
    Dept of Clinical Studies, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania
  • R. Kuchtey
    Vanderbilt University, Nashville, Tennessee
    Dept of Ophthalmology and Visual Sciences,
  • Footnotes
    Commercial Relationships J. Kuchtey, None; M. Curtis, None; K. Gelatt, None; M. Kallberg, None; T. Rinkoski, None; A. Komaromy, None; R. Kuchtey, None.
  • Footnotes
    Support Fight for Sight; Vanderbilt Vision Research Center; Research to Prevent Blindness; EY15398
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3951. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Invetigation of Cornea-Derived Transcript 6 (CDT6) as a Potential Glaucoma Protein
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      J. Kuchtey, M. Curtis, K. Gelatt, M. Kallberg, T. Rinkoski, A. Komaromy, R. Kuchtey; Invetigation of Cornea-Derived Transcript 6 (CDT6) as a Potential Glaucoma Protein. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3951.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose:: To investigate the role of cornea-derived transcript 6 (CDT6) protein in the pathogenesis of glaucoma.

Methods:: Primary human trabecular meshwork (TM) cells were stimulated with dexamethasone and transforming growth factor beta (TGFb), and CDT6 protein levels in supernatants were determined by Western blotting. Localization of CDT6 protein in human anterior segment tissue was determined by immunohistochemistry. The levels of CDT6 protein in aqueous humor (AH) from glaucoma patients were compared with that obtained from non-glaucoma patients undergoing cataract surgery. The beagle model of primary open-angle glaucoma (POAG) was used to monitor CDT6 protein levels in canine AH with disease progression.

Results:: In human anterior segment tissue, CDT6 protein expression was highest in the deep stromal layer of cornea, near Schlemm's canal in the limbus, while the TM expressed little or no CDT6. Its differential express in the cornea and TM was confirmed by Western blotting. Secretion of CDT6 protein was induced by treatment of primary TM cells with dexamethasone, TGFb -1 and TGFb -2. More CDT6 protein was found in AH of glaucoma patients, as compared to controls. In individual POAG beagle dogs, the levels of CDT6 protein in the AH obtained every 6 months increased as severity of POAG progressed.

Conclusions:: CDT6 is a secreted protein primarily produced by corneal cells and released into AH. The possibility that CDT6 protein is involved in glaucoma pathogenesis is supported by the fact that it is induced by dexamethasone and TGFb. Increased levels of CDT6 protein in AH of glaucoma patients is consistent with a pathogenic role. The increase in CDT6 protein in AH of POAG beagles, which are not treated with glaucoma medications, is also consistent with a pathogenic role of CDT6 protein in the development of glaucoma. The effect of CDT6 on the AH outflow facility through excessive deposition of extracellular matrix, and the mechanism of CDT6 induction by dexamethasone are currently being investigated.

Keywords: aqueous • extracellular matrix • trabecular meshwork 
© 2007, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept